GlassScriptPhysician profile
Neil Patel
NPI 1699341263
$2,094.03
in general payments reported to CMS, 2019-2025
12 companies · $981 in 2025
The $981 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $136 · 2022: $523 · 2023: $282 · 2024: $172 · 2025: $981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,435.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $578.99 | 2022-2025 | |
| Madrigal Pharmaceuticals | $231.43 | 2025 | Rezdiffra |
| Gilead Sciences, INC. | $221.23 | 2025 | Livdelzi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $196.88 | 2022 | |
| Mallinckrodt Hospital Products INC. | $147.17 | 2024 | Terlivaz |
| Takeda Pharmaceuticals U.S.A., INC. | $135.59 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $124.74 | 2022 | |
| Janssen Biotech, INC. | $124.74 | 2025 | Tremfya |
| Nestle Healthcare Nutrition INC. | $124.01 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $105.34 | 2025 | Iqirvo |
| Medtronic, INC. | $72.98 | 2023-2024 | Interstim, Pillcam |
| Steris Corporation | $30.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.